Industry News
News for Providers
Top stories summarized by our editors
6/2/2020

Women in radiology are facing difficulties balancing career and childcare responsibilities as they work remotely during the COVID-19 pandemic, and a study in Nature found that the pandemic has led to fewer study uploads in preprint servers from female radiologists, said ACR President Dr. Geraldine McGinty. Female radiologists can take on greater leadership roles or increase their influence during the pandemic by thinking about their roles and writing on their experiences during this health crisis, McGinty said. Many radiology practices will struggle financially amid the pandemic due to delays in non-essential imaging, McGinty said, but the ACR remains committed to maintaining patient access to imaging and preserving radiologist wellness.

Full Story:
Diagnostic Imaging
6/2/2020

A systematic review of 172 studies on coronavirus transmission found that physical distancing and use of face masks and eye protection are the best ways to reduce the risk of COVID-19. The findings, published in The Lancet, showed good hygiene and regular hand-washing are also critical in preventing SARS, MERS and COVID-19.

Full Story:
Reuters, CNN
6/2/2020

FDA Commissioner Stephen Hahn said the agency is considering permanently implementing some of the policies and processes adopted in response to the COVID-19 pandemic. Most of the changes "represent an acceleration of where we were headed before," including increased use of telemedicine, backing for decentralized clinical studies and work on laboratory-developed tests, Hahn said.

Full Story:
Regulatory Focus
6/2/2020

Social workers are "social architects" who have the opportunity right now to promote racial equity and advocate for change, writes social worker Lakeya Cherry. "A failure to take explicit action to promote race equity is equivalent to maintaining and supporting oppressive and racist systems," she writes.

6/2/2020

Male college students who were moderate or heavy video game players ate more saturated fat than those who did not play video games, and those who were moderate gamers consumed more salt than those who did not play video games, according to data presented at Nutrition 2020 Live Online. Heavy video game playing was associated with consuming more discretionary calories, when compared with not playing, and men who were moderate and heavy video game users consumed fewer fruits and vegetables.

6/2/2020

A study in JAMA Internal Medicine found that the mean annual out-of-pocket spending on diabetes-related supplies was higher compared with the mean annual out-of-pocket spending for insulin, which only accounted for 18% of the overall out-of-pocket spending, among 65,192 patients with type 1 diabetes. The findings also revealed that children had higher use of diabetes technologies and out-of-pocket spending for diabetes-related supplies than adults, and they also spend more on diabetes-related supplies than insulin.

Full Story:
HCPLive Network
6/2/2020

Adults who took statins, particularly hydrophilic and lipophilic statins, had higher levels of insulin resistance, compared with those who didn't take statins, according to a study in the Journal of the Endocrine Society. The researchers, who based the findings on data from 609 older adults, noted that "consideration for choosing non-lipophilic statins and avoidance of rosuvastatin and lipophilic statins may provide the intended cardiovascular protection without the increased incidence of insulin resistance" among those at risk of diabetes.

Full Story:
Endocrinology Advisor
More Summaries:
rosuvastatin
6/2/2020

The investment crowdfunding platform OurCrowd said it plans to raise $100 million for its Pandemic Innovation Fund. The funding will be targeted at tech solutions for medical, business and other problems brought by pandemics and other health emergencies.

Full Story:
Forbes, Crowdfund Insider
6/2/2020

Many summer internships and fellowships for graduate students, aimed at developing the next generation of health care leaders, have been canceled due to the novel coronavirus pandemic. "We've got a whole generation of future leaders on the sidelines, and that's not where they should be at this point in their learning, career development and experience," said Andrew Garman, director of the Rush Center for Health System Leadership at Rush University.

Full Story:
HealthLeaders Media
6/2/2020

Eli Lilly's and Co.'s Cyramza, or ramucirumab, combined with Roche's Tarceva, or erlotinib, gained FDA approval as a first-line therapy for patients with previously untreated non-small cell lung cancer with EGFR mutations. The approval was based on data from a randomized late-stage trial that included 449 treatment-naive patients.

More Summaries:
Roche